"Naphthoquinones" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Naphthalene rings which contain two ketone moieties in any position. They can be substituted in any position except at the ketone groups.
| Descriptor ID |
D009285
|
| MeSH Number(s) |
D02.455.426.559.847.638.721 D02.806.550 D04.615.638.721
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Naphthoquinones".
Below are MeSH descriptors whose meaning is more specific than "Naphthoquinones".
This graph shows the total number of publications written about "Naphthoquinones" by people in this website by year, and whether "Naphthoquinones" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naphthoquinones" by people in Profiles.
-
Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma. Nat Commun. 2021 05 17; 12(1):2877.
-
Nanaomycin K inhibited epithelial mesenchymal transition and tumor growth in bladder cancer cells in vitro and in vivo. Sci Rep. 2021 04 28; 11(1):9217.
-
An elusive electron shuttle from a facultative anaerobe. Elife. 2019 06 24; 8.
-
Targeting Osteocytes to Attenuate Early Breast Cancer Bone Metastasis by Theranostic Upconversion Nanoparticles with Responsive Plumbagin Release. ACS Nano. 2017 07 25; 11(7):7259-7273.
-
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors. Cancer Cell. 2016 Dec 12; 30(6):940-952.
-
NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer. Mol Cancer Ther. 2016 07; 15(7):1757-67.
-
Survivin selective inhibitor YM155 promotes cisplatin-induced apoptosis in embryonal rhabdomyosarcoma. Int J Oncol. 2016 May; 48(5):1847-54.
-
Shikonin inhibits IFN-?-induced K17 over-expression of HaCaT cells by interfering with STAT3 signaling. Int J Clin Exp Pathol. 2015; 8(8):9202-7.
-
Inhibition of Mcl-1 with the pan-Bcl-2 family inhibitor (-)BI97D6 overcomes ABT-737 resistance in acute myeloid leukemia. Blood. 2015 Jul 16; 126(3):363-72.
-
Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma. Oncogene. 2015 Jul; 34(29):3770-9.